Insider Stock Trading History of Almstead Neil Gregory


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Almstead Neil Gregory since year 2005. The trader's CIK number is 1578850. At the time of this reporting, Almstead Neil Gregory is the Chief Technical Ops Officer of Ptc Therapeutics, Inc. . (stock ticker symbol PTCT). See this page for all insider trading activities at Ptc Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Almstead Neil Gregory since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-01-07 PTCT Ptc Therapeutics, Inc. Sale 653 34.75 22,691
2018-06-19 PTCT Ptc Therapeutics, Inc. Option Ex 20,000 10.85 217,000
2018-06-19 PTCT Ptc Therapeutics, Inc. Sale 20,000 48.27 965,500
2018-01-05 PTCT Ptc Therapeutics, Inc. Sale 703 18.03 12,675
2018-01-04 PTCT Ptc Therapeutics, Inc. Sale 77 17.67 1,360
2017-01-05 PTCT Ptc Therapeutics, Inc. Sale 78 11.82 921
2016-09-27 PTCT Ptc Therapeutics, Inc. Option Ex 10,000 10.85 108,500
2015-04-15 PTCT Ptc Therapeutics, Inc. Sale 9,511 68.69 653,358
2015-03-19 PTCT Ptc Therapeutics, Inc. Sale 20,370 70.85 1,443,255
2015-03-10 PTCT Ptc Therapeutics, Inc. Sale 79 70.71 5,586
2015-02-17 PTCT Ptc Therapeutics, Inc. Option Ex 3,904 10.85 42,358
2015-02-17 PTCT Ptc Therapeutics, Inc. Sale 3,904 53.97 210,679
2015-01-20 PTCT Ptc Therapeutics, Inc. Option Ex 25,100 10.85 272,335
2015-01-21 PTCT Ptc Therapeutics, Inc. Option Ex 996 10.85 10,806
2015-01-20 PTCT Ptc Therapeutics, Inc. Sale 25,100 60.63 1,521,938
2015-01-21 PTCT Ptc Therapeutics, Inc. Sale 996 60.00 59,760
2014-12-04 PTCT Ptc Therapeutics, Inc. Sale 175 50.00 8,750
2014-03-19 PTCT Ptc Therapeutics, Inc. Sale 10,859 32.05 348,085

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Almstead Neil Gregory (Chief Technical Ops Officer of Ptc Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.